- Previous Close
0.0250 - Open
0.0000 - Bid --
- Ask --
- Day's Range
0.0000 - 0.0000 - 52 Week Range
0.0000 - 0.0650 - Volume
0 - Avg. Volume
220,627 - Market Cap (intraday)
2.085M - Beta (5Y Monthly) -2.35
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0100 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Diagnamed Holdings Corp. engages in the development and commercialization of AI healthcare solutions. It focuses on developing BRAIN AGE BRAIN HEALTH, a brain health AI platform leveraging that aims to predict and monitor brain age and provide actionable insights for mental health and neurodegenerative disorders; and CERVAI, brain health and wellness AI solution. It has a collaboration agreement with EIREX for the development and commercialization of EIREX's novel modular carbon-free technology that extracts hydrogen from water. Diagnamed Holdings Corp. is headquartered in Toronto, Canada.
www.diagnamed.com--
Full Time Employees
September 30
Fiscal Year Ends
Sector
Industry
Recent News: DMED.CN
View MorePerformance Overview: DMED.CN
Trailing total returns as of 3/19/2025, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: DMED.CN
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: DMED.CN
View MoreValuation Measures
Market Cap
2.09M
Enterprise Value
1.97M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
--
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-109.64%
Return on Equity (ttm)
--
Revenue (ttm)
--
Net Income Avi to Common (ttm)
-674.89k
Diluted EPS (ttm)
-0.0100
Balance Sheet and Cash Flow
Total Cash (mrq)
114.33k
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
-136.24k